List of works - Matti Hero

Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children.

scientific article published on 12 October 2012

Aromatase Inhibitors and Growth Disorders

Aromatase Inhibitors in the Treatment of Short Stature

scientific article published on 10 December 2015

Aromatase inhibitors in pediatrics

scientific article

Blockade of oestrogen biosynthesis in peripubertal boys: effects on lipid metabolism, insulin sensitivity, and body composition

article

Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism

scientific article

Childhood growth in boys with congenital hypogonadotropic hypogonadism

scientific article published on 31 December 2015

Childhood growth of females with Kallmann syndrome and FGFR1 mutations

scientific article published on 25 June 2014

Circulating antiandrogenic activity in children with congenital adrenal hyperplasia during peroral flutamide treatment

scientific article published on 28 June 2005

Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B.

scientific article published on 9 March 2012

Circulating makorin ring finger protein 3 levels decline in boys before the clinical onset of puberty

scholarly article by Tero Varimo et al published June 2016 in European Journal of Endocrinology

Circulating makorin ring-finger protein-3 (MKRN3) levels in healthy men and in men with hypogonadotropic hypogonadism

scientific article published on 06 August 2015

Circulating makorin ring-finger protein-3 (MKRN3) levels in healthy men and in men with hypogonadotropic hypogonadism

scientific article published on 01 April 2016

Cognitive effects of aromatase inhibitor therapy in peripubertal boys

scientific article published on 26 April 2010

Congenital Isolated Adrenocorticotropin Deficiency: An Underestimated Cause of Neonatal Death, Explained byTPITGene Mutations

scientific article published on 21 December 2004

Congenital hypogonadotropic hypogonadism, functional hypogonadotropism or constitutional delay of growth and puberty? An analysis of a large patient series from a single tertiary center

scientific article published on 6 December 2016

Health-related quality of life in male patients with congenital hypogonadotropic hypogonadism

scientific article published on 27 January 2015

Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature

scientific article

Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial

scientific article published on 27 September 2005

Pubertal upregulation of erythropoiesis in boys is determined primarily by androgen

scientific article published in February 2005

Recessive MED with auricular swelling due to compound heterozygosity Arg279Tpr/Thr512Lys in theSLC26A2gene

article

Recombinant Human FSH Treatment Outcomes in Five Boys With Severe Congenital Hypogonadotropic Hypogonadism

scientific article published on 15 October 2018

Serum FGF21 in boys with idiopathic short stature: relationship to lipid profile, onset of puberty and growth*

Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome

scientific article published on 22 August 2006

Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty

scientific article

Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty

scientific article published in July 2010

List of works by Matti Hero

Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children.

Aromatase Inhibitors and Growth Disorders

Aromatase Inhibitors in the Treatment of Short Stature

Aromatase inhibitors in pediatrics

Blockade of oestrogen biosynthesis in peripubertal boys: effects on lipid metabolism, insulin sensitivity, and body composition

Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism

Childhood growth in boys with congenital hypogonadotropic hypogonadism

Childhood growth of females with Kallmann syndrome and FGFR1 mutations

Circulating antiandrogenic activity in children with congenital adrenal hyperplasia during peroral flutamide treatment

Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B.

Circulating makorin ring finger protein 3 levels decline in boys before the clinical onset of puberty

Circulating makorin ring-finger protein-3 (MKRN3) levels in healthy men and in men with hypogonadotropic hypogonadism

Circulating makorin ring-finger protein-3 (MKRN3) levels in healthy men and in men with hypogonadotropic hypogonadism

Cognitive effects of aromatase inhibitor therapy in peripubertal boys

Congenital Isolated Adrenocorticotropin Deficiency: An Underestimated Cause of Neonatal Death, Explained byTPITGene Mutations

Congenital hypogonadotropic hypogonadism, functional hypogonadotropism or constitutional delay of growth and puberty? An analysis of a large patient series from a single tertiary center

Health-related quality of life in male patients with congenital hypogonadotropic hypogonadism

Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature

Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial

Pubertal upregulation of erythropoiesis in boys is determined primarily by androgen

Recessive MED with auricular swelling due to compound heterozygosity Arg279Tpr/Thr512Lys in theSLC26A2gene

Recombinant Human FSH Treatment Outcomes in Five Boys With Severe Congenital Hypogonadotropic Hypogonadism

Serum FGF21 in boys with idiopathic short stature: relationship to lipid profile, onset of puberty and growth*

Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome

Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty

Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty

Zoledronic Acid Treatment in Children with Osteogenesis Imperfecta